AU6541894A - Arylethanolamine derivatives and their use in the treatment of obesity and hyperglycaemia - Google Patents

Arylethanolamine derivatives and their use in the treatment of obesity and hyperglycaemia

Info

Publication number
AU6541894A
AU6541894A AU65418/94A AU6541894A AU6541894A AU 6541894 A AU6541894 A AU 6541894A AU 65418/94 A AU65418/94 A AU 65418/94A AU 6541894 A AU6541894 A AU 6541894A AU 6541894 A AU6541894 A AU 6541894A
Authority
AU
Australia
Prior art keywords
hyperglycaemia
obesity
treatment
arylethanolamine derivatives
arylethanolamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65418/94A
Other languages
English (en)
Inventor
Lee James Beeley
John Michael Berge
Richard Anthony Godwin Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU6541894A publication Critical patent/AU6541894A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/708—Ethers
    • C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/32—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups bound to acyclic carbon atoms and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU65418/94A 1993-04-21 1994-04-19 Arylethanolamine derivatives and their use in the treatment of obesity and hyperglycaemia Abandoned AU6541894A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9308178 1993-04-21
GB939308178A GB9308178D0 (en) 1993-04-21 1993-04-21 Novel compounds
PCT/GB1994/000829 WO1994024090A1 (en) 1993-04-21 1994-04-19 Arylethanolamine derivatives and their use in the treatment of obesity and hyperglycaemia

Publications (1)

Publication Number Publication Date
AU6541894A true AU6541894A (en) 1994-11-08

Family

ID=10734172

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65418/94A Abandoned AU6541894A (en) 1993-04-21 1994-04-19 Arylethanolamine derivatives and their use in the treatment of obesity and hyperglycaemia

Country Status (5)

Country Link
AU (1) AU6541894A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB9308178D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TW282452B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1994024090A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA942674B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2758460B1 (fr) * 1997-01-21 1999-12-31 Sanofi Sa Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
US20100173829A1 (en) * 2008-11-07 2010-07-08 Aston University Glycoproteins Having Lipid Mobilizing Properties and Therapeutic Uses Thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0023385B1 (en) * 1979-06-16 1982-12-15 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
DE3662521D1 (de) * 1985-04-16 1989-04-27 Hoffmann La Roche Phenethanol amine derivatives
GB8620951D0 (en) * 1986-08-29 1986-10-08 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
WO1994024090A1 (en) 1994-10-27
ZA942674B (en) 1995-03-20
TW282452B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1996-08-01
GB9308178D0 (en) 1993-06-02

Similar Documents

Publication Publication Date Title
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU3130993A (en) Retractor and associated method for use in laparoscopic surgery
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
AU3119495A (en) Surgical product and its use
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
AU3725997A (en) S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders
AU7319994A (en) Nucleotide preparation and uses thereof in wound healing
AU3099997A (en) The use of tcet in the prophylaxis and treatment of allergies
AP9500727A0 (en) 13-substituted milbemy in derivatives their preparation and use
AU7384094A (en) Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders
SG47611A1 (en) Improvements in or relating to clamps and the use thereof
AU7216996A (en) A paf-acetylhydrolase and use in therapy
AU3697395A (en) Sitting and training surface
AU3634595A (en) Bis-oxazolidines and their use
AU6541894A (en) Arylethanolamine derivatives and their use in the treatment of obesity and hyperglycaemia
AU2705495A (en) Use of rooperol and hypoxoside and their derivatives in the treatment of inflammatory
AU2115197A (en) Compositions and methods useful in the detection and/or treatment of cancerous conditions
AU5975094A (en) 1,2,4-triazinone derivatives and their use in therapy
AU4177196A (en) Use of inflammatory modulators in the treatment of chronic or recalcitrant skin damage
AU1485197A (en) Diamines in the treatment of arrhythmia
EP0893123A4 (en) MEANS OF PREVENTIVE AND CURATIVE TREATMENT OF CONDITIONS RELATED TO DIFFERENT FORMS OF AGING OF THE ORGANISM
AU7078094A (en) Allatostatins and their use
AU1745092A (en) Thiazolidine derivatives and their use in therapy
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
IL109356A0 (en) N-substituted-2-azetidinones and their use in the preparation of n-unsubstituted-2-azetidinones